So-Young International Inc.

NASDAQ:SY

Medical - Healthcare Information Services

Healthcare
$1.83 -5.83%

-$0.09 today

Market cap
$239.36M
Beta
1.98
P/E (TTM)
-5.0
EPS (TTM)
-$1.95
52W Low $1.00High $6.28

Volume 0.46M

Average 0.63M

SY Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

So-Young International Inc.NASDAQ: SY

Other Income / Expenses · Q1 FY2026 · quarter ended Mar 2026

Other income / expenses declines year over year

Q1 FY2026 other income / expenses of CN¥6.89M fell 20.4% year over year, ahead of the -39.5% change in trailing-twelve-month other income / expenses. Over 3 fiscal years it compounded at +8.0% a year.

Context

  • Other income / expenses amounted to 1.3% of revenue in FY2025, down 1.1 pp from a year earlier.
  • Other income / expenses increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of -20.4% holds above the trailing-twelve-month pace of -39.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
CN¥6.89M+160.8% QoQ
Last fiscal yearDec 2025
CN¥19.8M-45.6% YoY
LTMMar 2026
CN¥18.75M-39.5% YoY
Other Income / Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-20.4%——
1 year-45.6%——
3-year CAGR+8.0%——
5-year CAGR——
10-year CAGR——

Other Income / Expenses history

CNY · from the income statement

Latest · FY2025
19.8M CNY
Year-over-year change
-45.6%
4-year CAGR
+5.2%

Other Income / Expenses vs competitors

How SY compares with its peers on the latest reported figures

  • Peers report in different currencies, so other income / expenses is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -39.5% is the 6th highest of 11, against a peer median of -58.8%.
  • Other income / expenses amounts to 1.1% of revenue for SY, versus a peer median of 7.4%.
SY Competitors
Other Income / Expenses for SY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
OMEROmeros CorporationLTM Mar 2026$191.32M USD+1815.8%—1933.9%
CGEMCullinan Therapeutics, Inc.LTM Mar 2026$19.31M USD-36.3%+48.3%—
SYSo-Young International Inc.LTM Mar 2026CN¥18.75M CNY-39.5%+8.0%1.1%
SLPSimulations Plus, Inc.LTM Feb 2026$925K USD-81.4%+87.8%1.1%
NMRANeumora Therapeutics, Inc. Common StockLTM Mar 2026$745K USD-95.5%-4.3%—
LXRXLexicon Pharmaceuticals, Inc.LTM Mar 2026-$1.86M USD-1250.0%—2.7%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026-$7.92M USD-764.8%—9.8%
LABStandard BioTools Inc.LTM Mar 2026-$9.32M USD-198.2%—10.8%
SNDASonida Senior Living, Inc.LTM Mar 2026-$15.92M USD+44.3%—3.9%
ADCTADC Therapeutics S.A.LTM Mar 2026-$17.66M USD+27.0%—22.3%
VREXVarex Imaging CorporationLTM Apr 2026-$43.8M USD-18.7%—5.1%
Peer median (excluding SY) —-58.8%+48.3%7.4%

Competitors are the stored peer set for SY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CNY
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.69B1.26B1.5B1.47B1.48B
Cost of Revenue327.89M393.29M544.34M567.59M774.04M
Gross Profit1.36B864.58M953.69M899.11M707.86M
Gross Margin80.6%68.7%63.7%61.3%47.8%
Research & Development286.57M235.09M203.52M165.03M133.31M
Selling, General & Admin1.04B732.3M811.22M818.57M833.76M
Operating Expenses1.4B967.39M1.01B1.52B967.07M
Depreciation & Amortization30.08M47.09M46.09M46.09M57.21M
EBITDA63.39M(39.99M)53.96M(38.39M)(182.19M)
EBITDA Margin3.7%-3.2%3.6%-2.6%-12.3%
Operating Income(32.57M)(102.81M)(61.05M)(624.49M)(259.21M)
Operating Margin-1.9%-8.2%-4.1%-42.6%-17.5%
Interest Income19.33M28.88M48.84M46.51M24.6M
Interest Expense00000
Other Income / Expenses16.17M15.73M68.92M36.41M19.8M
Income Before Tax(16.41M)(87.07M)7.87M(588.09M)(239.4M)
Pre-Tax Margin-1.0%-6.9%0.5%-40.1%-16.2%
Income Tax Expense21.23M(20.97M)(18.08M)(905K)(774.31K)
Net Income(8.37M)(65.55M)21.28M(589.53M)(235.7M)
Net Margin-0.5%-5.2%1.4%-40.2%-15.9%
EPS (Basic)(0.06)(0.48)0.16(4.40)(1.78)
EPS (Diluted)(0.06)(0.48)0.16(4.39)(1.78)
Weighted Avg Shares138.04M138.04M133.19M134.09M131.59M
Weighted Avg Shares (Diluted)138.04M138.04M131.91M134.16M131.59M

So-Young International Inc.

NASDAQ:SY

Intrinsic Alpha fair value

Locked

Current Price

$1.83

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.